US 10913761
2,7-dibromospiro[fluorene-9,4′-piperidine] compounds
granted A61KA61K31/7028A61K31/7034
Quick answer
US patent 10913761 (2,7-dibromospiro[fluorene-9,4′-piperidine] compounds) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7028, A61K31/7034, A61K31/7036, A61K31/7042